BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
G-protein-coupled receptor binding
,
Diabetes mellitus
,
Lung
,
Neocentromeres
,
PRKCA
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
HIF1- α
Summary
General Info
Curated Studies
Most Correlated Studies
Chronic myelogenous leukemia cells in normoxic or hypoxic culture treated with imatinib
Maternal Diabetes alters Transcriptional Programs in the Developing Embryo
Explore Curated Studies Results
Literature
Most Relevant Literature
HIF1-α upregulation induces proinflammatory factors to boost host killing capacity after Aspergillus…
Overactivated NRF2 induces pseudohypoxia in hepatocellular carcinoma by stabilizing HIF-1α.
Hypoxia-mediated stabilization of HIF1A in prostatic intraepithelial neoplasia promotes cell plastic…
Hypoxia-Inducible Factor-1α in Rods Is Neuroprotective Following Retinal Detachment.
HIF1α stabilization in hypoxia is not oxidant-initiated.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Carnosine for Peripheral Vascular Disease
Isolated and Combined Effect of a Low Carbohydrate Diet and Exercise in Hypoxia in Patients With Typ…
First-line Irinotecan, Lederfolin and 5FU (FOLFIRI) and Bevacizumab in Patients With Advanced Colore…
Clock Genes in Patients With Refractory Septic Shock (SeptiClock) - Pilot Study
17AAG to Treat Kidney Tumors in Von Hippel-Lindau Disease
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ